Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/118195
Full metadata record
DC FieldValueLanguage
dc.creatorMesquita, I
dc.creatorMoreira, D
dc.creatorSampaio-Marques, B
dc.creatorLaforge, M
dc.creatorCordeiro-da-Silva, A
dc.creatorLudovico, P
dc.creatorEstaquier, J
dc.creatorSilvestre, R
dc.date.accessioned2019-01-08T09:55:07Z-
dc.date.available2019-01-08T09:55:07Z-
dc.date.issued2016
dc.identifier.issn1664-431X
dc.identifier.urihttps://repositorio-aberto.up.pt/handle/10216/118195-
dc.description.abstractDuring host-pathogen interactions, a complex web of events is crucial for the outcome of infection. Pathogen recognition triggers powerful cellular signaling events that is translated into the induction and maintenance of innate and adaptive host immunity against infection. In opposition, pathogens employ active mechanisms to manipulate host cell regulatory pathways toward their proliferation and survival. Among these, subversion of host cell energy metabolism by pathogens is currently recognized to play an important role in microbial growth and persistence. Extensive studies have documented the role of AMP-activated protein kinase (AMPK) signaling, a central cellular hub involved in the regulation of energy homeostasis, in host-pathogen interactions. Here, we highlight the most recent advances detailing how pathogens hijack cellular metabolism by suppressing or increasing the activity of the host energy sensor AMPK. We also address the role of lower eukaryote AMPK orthologues in the adaptive process to the host microenvironment and their contribution for pathogen survival, differentiation, and growth. Finally, we review the effects of pharmacological or genetic AMPK modulation on pathogen growth and persistence.
dc.description.sponsorshipThis work was supported by grants to JE from the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) and from The Canadian HIV Cure Enterprise Team Grant HIG-13305 from the Canadian Institutes of Health Research (CIHR) in partnership with CANFAR and IAS. JE acknowledges the support of the Canada Research Chair I. Mesquita et al. program. It was also supported by FCT—Fundação para a Ciência e a Tecnologia/MEC — Ministério da Educação e Ciência através de fundos nacionais e quando aplicável cofinanciado pelo FEDER, no âmbito do Acordo de Parceria PT2020 referente à unidade de investigação nº 4293. DMis supported by SFRH/BD/91543/2012. RS is supported by the Fundação para a Ciência e Tecnologia (FCT) (IF/00021/2014).
dc.language.isoeng
dc.publisherSpringer
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F91543%2F2012/PT
dc.relation.ispartofExperientia Supplementum, vol.107, p. 287-323
dc.rightsopenAccess
dc.subject.meshAMP-Activated Protein Kinases/antagonists & inhibitors
dc.subject.meshAMP-Activated Protein Kinases/genetics
dc.subject.meshAMP-Activated Protein Kinases/immunology
dc.subject.meshAnti-Infective Agents/therapeutic use
dc.subject.meshAutophagy/drug effects
dc.subject.meshAutophagy/immunology
dc.subject.meshBacteria/drug effects
dc.subject.meshBacteria/genetics
dc.subject.meshBacteria/metabolism
dc.subject.meshBacterial Infections/drug therapy
dc.subject.meshBacterial Infections/enzymology
dc.subject.meshBacterial Infections/genetics
dc.subject.meshBacterial Infections/virology
dc.subject.meshFungi/drug effects
dc.subject.meshFungi/enzymology
dc.subject.meshFungi/genetics
dc.subject.meshGene Expression Regulation
dc.subject.meshHost-Pathogen Interactions/drug effects
dc.subject.meshHost-Pathogen Interactions/genetics
dc.subject.meshHumans
dc.subject.meshImmunity, Innate/drug effects
dc.subject.meshMolecular Targeted Therapy
dc.subject.meshMycoses/drug therapy
dc.subject.meshMycoses/enzymology
dc.subject.meshMycoses/genetics
dc.subject.meshMycoses/virology
dc.subject.meshProtein Subunits/antagonists & inhibitors
dc.subject.meshProtein Subunits/genetics
dc.subject.meshProtein Subunits/immunology
dc.subject.meshProtein-Serine-Threonine Kinases/antagonists & inhibitors
dc.subject.meshProtein-Serine-Threonine Kinases/genetics
dc.subject.meshProtein-Serine-Threonine Kinases/immunology
dc.subject.meshSignal Transduction
dc.subject.meshVirus Diseases/drug therapy
dc.subject.meshVirus Diseases/enzymology
dc.subject.meshVirus Diseases/genetics
dc.subject.meshVirus Diseases/virology
dc.subject.meshViruses/drug effects
dc.subject.meshViruses/genetics
dc.subject.meshViruses/metabolism
dc.titleAMPK in Pathogens
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1007/978-3-319-43589-3_12
dc.relation.publisherversionhttps://link.springer.com/chapter/10.1007%2F978-3-319-43589-3_12
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Mesquita2016.pdf817.78 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.